65,359 results on '"coronavirus disease 2019 (COVID‐"'
Search Results
2. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020
3. Meta-analysis Comparing Outcomes in Patients With and Without Cardiac Injury and Coronavirus Disease 2019 (COVID 19)
4. C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.
5. Evaluation of the Role of Hemoperfusion on Mortality and Morbidity in Patients with Severe Coronavirus Disease 2019 (COVID- 19)
6. Sexual health service adaptations to the coronavirus disease 2019 (COVID?19) pandemic in Australia: a nationwide online survey
7. Mortality in patients with Coronavirus disease 2019 (COVID- 19) and its clinicoradiological and laboratory correlates: A retrospective study
8. Post-acute coronavirus disease 2019 (COVID 19) syndrome: HLH and cholangiopathy in a lung transplant recipient
9. Risk Communication in Public Health Practices and Coronavirus Disease 2019 (COVID -19): Social Media Analysis of Health Authorities
10. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID 19): What we know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects
11. EVALUASI KEJADIAN IKUTAN PASCA IMUNISASI KIPI PADA VAKSINASI CORONAVIRUS DISEASE 2019 COVID 19 DI PUSKESMAS KABUPATEN MALANG
12. Model of Surveillance Prevention and Control Coronavirus Disease 2019 (COVID 19) in Samutprakan Central Prison
13. CO RADS grade of HRCT Thorax and RT PCR testing for the diagnosis of coronavirus disease 2019 (COVID 19): A descriptive hospital based study of asymptomatic planned surgery cases.
14. WhatsApp Messenger role in Coronavirus Disease 2019 (COVID 19) Pandemic
15. Internet addiction is likely to increase in home quarantine caused by coronavirus disease 2019 (COVID 19)
16. EVALUASI KEJADIAN IKUTAN PASCA IMUNISASI KIPI PADA VAKSINASI CORONAVIRUS DISEASE 2019 COVID 19 DI PUSKESMAS KABUPATEN MALANG
17. Kaempferol has potential anti‐coronavirus disease 2019 ( COVID ‐19) targets based on bioinformatics analyses and pharmacological effects on endotoxin‐induced cytokine storm
18. Sosialisasi Upaya Preventif Penyebaran Coronavirus Disease 2019 (COVID) di SMAN 15 Muaro Jambi
19. Age and gender profile of coronavirus disease 2019 (COVID 19) in Quarantine Center in Baghdad, Iraq
20. Contribution of Chinese herbal medicine in the treatment of coronavirus disease 2019 ( COVID ‐19): A systematic review and meta‐analysis of randomized controlled trials
21. Coronavirus disease 2019 ( COVID ‐19): Focus on peripheral blood cell morphology
22. Subtle vascular and astrocytic changes in the brain of coronavirus disease 2019 ( COVID ‐19) patients
23. Coronavirus disease 2019 (COVID 19) induced acute necrotizing pancreatitis in a female child: A case report.
24. Decreases in the urban heat island effect during the Coronavirus Disease 2019 ( COVID ‐19) lockdown in Wuhan, China: Observational evidence
25. Post-acute coronavirus disease 2019 (COVID 19) syndrome
26. Clinical Profiles of Children (0 - 18 Years Old and 364 days) with Coronavirus Disease 2019 (COVID 19) at St. Luke’s Medical Center Quezon City
27. United States : Notice on the Continuation of the National Emergency Concerning the Coronavirus Disease 2019 (COVID-?19) Pandemic
28. NOTICE ON THE CONTINUATION OF THE NATIONAL EMERGENCY CONCERNING THE CORONAVIRUS DISEASE 2019 (COVID-A 19) PANDEMIC
29. LETTERS TO THE SPEAKER OF THE HOUSE OF REPRESENTATIVES AND THE PRESIDENT OF THE SENATE ON THE CONTINUATION OF THE NATIONAL EMERGENCY CONCERNING THE CORONAVIRUS DISEASE 2019 (COVID-A 19) PANDEMIC
30. Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?
31. Automated measurement of coagulation and fibrinolytic activation markers: Outcomes in coronavirus disease 2019 ( COVID ‐19) patients
32. Predictors of ICU Admission and Mortality in Patients with Coronavirus Disease – 2019 (COVID 19) in Community Hospitals
33. Outcomes of nutritionally at-risk Coronavirus Disease 2019 (COVID 19) patients admitted in a tertiary government hospital: A follow-up study of the MalnutriCoV study
34. Convalescent plasma in hospitalized pediatric and obstetric coronavirus disease 2019 ( COVID ‐19) patients
35. Influence of the coronavirus disease 2019 ( COVID ‐19) pandemic on the incidence of heat stroke and heat exhaustion in Japan: a nationwide observational study based on the Heatstroke STUDY 2019 (without COVID ‐19) and 2020 (with COVID ‐19)
36. Mortality in patients with Coronavirus disease 2019 (COVID- 19) and its clinicoradiological and laboratory correlates: A retrospective study
37. Commentary: Coronavirus disease 2019 (COVID 19): Adaptive realignment makes me want to work eight days a week
38. A Venture to Discover the Treatment of Coronavirus Disease 2019 (COVID 19): SARS-CoV-2
39. MANAGEMENT OF CORONAVIRUS DISEASE 2019 (COVID - 19) – IS THERE A ROLE FOR COMPLEMENTARY AND HERBAL MEDICINAL PRODUCTS?
40. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020
41. Risk Factor and Clinical Outcomes of Coronavirus Disease 2019 (COVID -19) Patients in TAK Province, Thailand
42. The prevalence of malnutrition and analysis of related factors among adult patients with the Coronavirus Disease 2019 (COVID 19) in a tertiary government hospital: The MalnutriCoV study.
43. Clinical Profiles of Children (0 - 18 Years Old and 364 days) with Coronavirus Disease 2019 (COVID 19) at St. Luke’s Medical Center Quezon City
44. Hearing test results of newborns born from the coronavirus disease 2019 ( COVID ‐19) infected mothers: A tertiary center experience in Turkey
45. The Use of Oral Amino‐Bisphosphonates and Coronavirus Disease 2019 ( COVID ‐19) Outcomes
46. Psychosocial perspectives among cancer patients during the coronavirus disease 2019 ( COVID ‐19) crisis: An observational longitudinal study
47. Systematic review and meta‐analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 ( COVID ‐19): Evidence‐base for practise and implications for research
48. Outcomes of nutritionally at-risk Coronavirus Disease 2019 (COVID 19) patients admitted in a tertiary government hospital: A follow-up study of the MalnutriCoV study
49. A practical approach for the management of obstetric and infertile women during the phase two of the novel coronavirus disease 2019 (COVID -19) pandemic.
50. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.